核酸酶
核酸
寡核苷酸
体外
生物化学
化学
分子生物学
生物
免疫系统
体内
核糖核酸
DNA
核苷酸
肽核酸
生物活性
耐受性
药理学
毒性
核酸法
作者
Takaaki Kawanobe,Ajaya Ram Shrestha,Hideaki Tomita
出处
期刊:Nucleic Acid Therapeutics
[Mary Ann Liebert, Inc.]
日期:2026-10-29
卷期号:: 21593337261502560-21593337261502560
标识
DOI:10.1177/21593337261502560
摘要
Guanidine-bridged nucleic acid (GuNA) is a bridged nucleic acid analog with high binding affinity toward complementary strands along with high nuclease resistance. GuNA has been developed to improve pharmacokinetics and safety profiles of phosphorothioate modified gapmers. Here, we evaluated antisense oligonucleotides (ASOs) modified with combination of GuNA and 2′- O -methoxyethyl (MOE) and found that the dual-modification strategy could significantly improve knockdown activity in vitro and in vivo . Long-term efficacy evaluation showed that intracerebroventricularly administered GuNA-modified gapmers stayed active for over 24 weeks in mouse brain. Furthermore, we observed that GuNA-modified gapmers could evade lymphocyte-derived immune responses and kept ASO-induced toxicity in check. Taken together, the results of this study demonstrate that GuNA modification can improve the functional potential of ASOs, especially in the central nervous system.
科研通智能强力驱动
Strongly Powered by AbleSci AI